期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

HIV-1感染者中枢神经系统的病毒学特征研究 被引量：2

Research on virological characteristics in central nervous system of HIV-1 infected patients
下载PDF
导出
摘要 目的探讨HIV-1感染者中枢神经系统(CNS)的病毒学特征。方法通过克隆测序分析病毒亚型,观察CNS中HIV-1变异性和离散率;依据V3环11/25法则并结合10例有偿献血HIV-1感染者尸检脑组织标本免疫荧光试验分析中枢神经HIV-1复合受体的使用。结果有偿献血人群感染的HIV-1显示B和B′亚型特征,脑脊液(CSF)和外周血序列有嵌合现象;CSF C2-V5区序列变异性明显低于外周血,两者的离散率差异无统计学意义;依据11/25法则分析V3环序列可见中枢神经HIV-1大多数使用CCR5复合受体。结论 CNS HIV-1病毒变异性明显小于外周血;CNS HIV-1具有CCR5嗜性。 Objective To study the virological characteristics in central nervous system （CNS） of HIV-1 infected patients. Methods Virus subtype was analyzed by cloning and sequencing. Variability and discrete rate of HIV-1 in CNS were observed. Co-receptor usage of HIV-1 in CNS was characterized as according to V3-1oop 11/25 charge rule and fur- ther confirmed through immunoflourescence in autopsies of 10 HIV-1 infected professional blood donors （PBD）. Results HIV-1 from PBDs displayed features of subtypes B＂ and B. Sequence from cerebrospinal fluid （CSF） and peripheral blood had phenomenon of chimerism. C2 - V5 sequence variability in CSF was significantly lower than that in peripheral blood .However, there was no difference in sequence divergency between CNS and blood. Based on V3 loop sequence by the 11/25 rule analysis, most of HIV-1 in CNS used CCR5 coreceptor. Conclusion HIV-1 diversity in CNS is signifi- cantly lower than that in peripheral blood. HIV-1 in CNS has CCR5 tropism.
作者 丁渭 张玉林 乔录新 徐树莹 宋凤丽 陈德喜
机构地区 首都医科大学附属北京佑安医院北京市肝病研究所
出处 《北京医学》 CAS 2012年第12期1037-1040,1022,共4页 Beijing Medical Journal
基金 国家自然科学基金(30910103915)
关键词 中枢神经系统 人类免疫缺陷病毒1型 C2-V5区 病毒学特征 Central nervous system HIV-1 C2-V5 region Virological characteristic
分类号 R512.91 [医药卫生—内科学]
  • 相关文献

参考文献12

  • 1van Marie G, Power C. Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphe-nomenon or disease determinant? J Neuro Virol,2005,11:107-128.
  • 2Price RW, Brew B, Sidtis J, et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science, 1988,239:586-592.
  • 3Cheung R, Ravyn V, Wang L, et al. Signaling mechanism of HIV-1 gpl20 and virion-induced IL-lbeta release in primary human macrophages. J ImmunoI,2008,180:6675-6684.
  • 4Catani MV, Corasaniti MT, Navarra hi, et al. gpl20 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. J Neurochem,2000,74:2373-2379.
  • 5Tang YW, Huong JT, Lloyd RM Jr, et al. Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebmspinal fluid and plasma. J Clin Micmbiol,2000,38: 4637-4639.
  • 6Ohagen A, Devitt A, Kunstman K J, et al. Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J Vi- rol,2003,77: 12336-12345.
  • 7Chen Y, Craigo JK, Ding M, et al. Characterization of the gpl20 of circulating HIV type 1 in a group of infected Chinese blood/plasma donors with asymptomatic and symptomatic stages of the disease. AIDS Res Hum Retroviruses,2006,22:1167-1171.
  • 8Chun, H, Hao W, Honghai Z, et al. CCL3L1 prevents gpl20-in- duced neuron death via the CREB cell signaling pathway. Brain Res,2009,1257:75-88.
  • 9Saitoh A, Fenton T, Alvem C, et al. Impact of nucleoside reverse transcriptase inhibitors on mitoehondria in human immunodefi- eiency virus type 1-infected children reeeiving highly aetive an- tiretroviral therapy. Antimierob Agents Chemother,2007,51:4236- 4242.
  • 10Wei F, Wang X, Liu L, et al. Characterization of HIV type 1 env gene in cerebmspinal fluid and blood of infected Chinese pa- tients. AIDS Res Hum Retroviruses,2011,27:793-796.

同被引文献29

  • 1Clifford DB, Ances BM. HIV-associated neurocognitive disorder [J]. Lancet Infect Dis, 2013, 13:976-986.
  • 2Romani B, Engelbrecht S, Glashoff RH. Functions of Tat: the ver- satile protein of human immunodeficiency virus type 1 [J]. J Gen Virol, 2010, 91:1-12.
  • 3Tyor W, Fritz-French C, Nath A. Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disor- ders[J]. J Neurovirol, 2013, 19:515-522.
  • 4Wei F, Wang X, Liu L, et al. Characterization of HIV type 1 env gene in cerebrospinal fluid and blood of infected Chinese patients [J]. AIDS Res Hum Retroviruses, 2011, 27:793-796.
  • 5Liu L, Zhao Q, Wei F, et al. Genetic analysis of HIV type 1 env gene in cerebrospinal fluid and plasma of infected Chinese paid blood donors[J]. AIDS Res Hum Retroviruses, 2012, 28:106-109.
  • 6Mbonye U, Karn J. Transcriptional control of HIV latency: Cellu- lar signaling pathways, epigeneties, happenstance and the hope for a cure[J]. Virology, 2014, 454-455C:328-339.
  • 7Liu L, Zhang Y, Wei F, et al. Discordant genotypic resistance and HIV-1 genetic diversity from paired plasma and cerebrospinal fluid samples in Chinese settings [J]. J Neurovirol, 2013, 19: 131-136.
  • 8Fraternale A, Paoletti MF, Dominici S, et al. Modulation of Thl/Th2 immune responses to HIV -1 Tat by new pro-GSH molecules[J]. Vaccine, 2011, 29:6823-6829.
  • 9Del Valle L, Pina-Oviedo S. HIV disorders of the brain: pathology and pathogenesis[J]. Front Biosci ,2006, 11:718-732.
  • 10Gendelman HE, Persidsky Y, Ghorpade A, et al. The neuropatho- genesis of the AIDS dementia complex[J]. AIDS, 1997, 11 Suppl A: S35-45.

引证文献2

北京医学
2012年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部